Back to Search
Start Over
Update on the metabolic syndrome: hypertension.
- Source :
-
Current hypertension reports [Curr Hypertens Rep] 2009 Apr; Vol. 11 (2), pp. 150-5. - Publication Year :
- 2009
-
Abstract
- The presence of the metabolic syndrome identifies an individual at increased risk for diabetes, cardiovascular disease, and early mortality. However, the increased risk may vary by the absence or presence of hypertension. Current guidelines for the management of high blood pressure in the metabolic syndrome emphasize lifestyle modification as a first-line strategy. Pharmacologic treatment of elevated blood pressure in the metabolic syndrome may be necessary in the presence of other cardiovascular risk factors or to achieve adequate blood pressure control. Currently, there is no consensus as to which antihypertensive therapy should be used to treat hypertension in patients with the metabolic syndrome; it remains unclear whether achieving tight blood pressure control should outweigh the potential for development of glucose intolerance. Future research must focus on this issue given the high prevalence of the syndrome among hypertensive patients and high rates of progression to diabetes among those with the metabolic syndrome.
- Subjects :
- Antihypertensive Agents therapeutic use
Cardiovascular Diseases physiopathology
Cardiovascular Diseases therapy
Combined Modality Therapy
Diabetes Mellitus, Type 2 physiopathology
Diabetes Mellitus, Type 2 therapy
Female
Humans
Hypertension therapy
Insulin Resistance physiology
Life Style
Male
Metabolic Syndrome therapy
Randomized Controlled Trials as Topic
Risk Factors
Hypertension physiopathology
Metabolic Syndrome physiopathology
Subjects
Details
- Language :
- English
- ISSN :
- 1534-3111
- Volume :
- 11
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Current hypertension reports
- Publication Type :
- Academic Journal
- Accession number :
- 19278605
- Full Text :
- https://doi.org/10.1007/s11906-009-0026-5